Hoppa till huvudinnehåll

Molnupiravir för COVID-19-sjukdom

Lagevrio

Granskad av Sid DajaniSenast uppdaterad av Michael Stewart, MRPharmSSenast uppdaterad 15 dec 2024

Uppfyller patientens redaktionella riktlinjer

Molnupiravir is given to adults aged over 18 years when they have tested positive for COVID-19 and have at least one risk factor for developing severe illness.

Treatment should be started as soon as possible after diagnosis and within the first five days of symptoms.

The most common side-effects are feeling sick (nausea) and diarrhoea.

Överblick

  • Molnupiravir is an antiviral medicine for adults with mild to moderate COVID-19.

  • It helps stop the COVID-19 virus from spreading quickly in the body.

  • It is used for people at high risk of severe COVID-19, including those with certain long-term conditions.

  • Take four capsules every 12 hours for five days, swallowing them whole with water.

  • Start treatment as soon as possible after symptoms begin or after a positive test.

  • Common side-effects can include diarrhoea, feeling sick, or dizziness.

Denna sammanfattning har automatiskt genererats från artikelns innehåll för att hjälpa läsarna att snabbt förstå huvudpunkterna.

About molnupiravir

Typ av medicin

Antiviral agent

Används för

Treatment of mild to moderate COVID-19 disease in adults

Även kallad

Lagevrio®

Tillgänglig som

Kapslar

Molnupiravir is an antiviral agent that works by combining with viral RNA to stop the virus particles from replicating. If a virus can't replicate it won't be able to infect other cells in the body and the infection won't spread as quickly. Molnupiravir can reduce the severity of viral infections such as COVID-19.

Molnupiravir is used for adults who have tested positive for COVID-19 and have at least one risk factor for severe disease. Taking molnupiravir as soon as possible once COVID-19 symptoms have started can lower your risk of being severely ill or requiring hospitalisation.

People at high risk of severe COVID-19 disease include those with medical conditions such as long-term heart, lung, liver, kidney or nerve problems, people with diabetes and people with weakened immune systems.

Before taking molnupiravir capsules

Some medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before you start taking molnupiravir it is important that your doctor knows:

  • Om du är gravid, försöker bli gravid eller ammar.

  • Om du någonsin har haft en allergisk reaktion mot en medicin.

  • Om du tar några andra läkemedel. Detta inkluderar alla läkemedel du tar som finns att köpa utan recept, samt växtbaserade och komplementära läkemedel.

How to take molnupiravir capsules

  • Before you start this treatment, read the manufacturer's printed information leaflet from inside your pack. The manufacturer's leaflet will give you more information about molnupiravir and a full list of side-effects which you may experience from taking it.

  • The usual dose of molnupiravir is four capsules (800 mg) taken every twelve hours for five days. Make sure you complete the course even if you are feeling better.

  • Swallow the capsules whole with a drink of water. Do not open, crush or chew the capsules.

  • It is not important whether you take molnupiravir capsules before or after food.

  • If you forget to take a dose, take it as soon as you remember unless it is nearly time for your next dose. In which case, leave out the forgotten dose and take your next dose when it is due. Do not take two doses together to make up for a missed dose.

Få ut det mesta av din behandling

  • Treatment with molnupiravir should be started within the first five days of COVID-19 symptoms or as soon as possible after a positive COVID-19 test result.

  • Make sure you complete the full course of treatment even if you start to feel better or do not feel unwell.

  • Help your body fight the infection by drinking plenty of water, eating sensibly and getting plenty of rest.

  • The best way to protect yourself from COVID-19 is through vaccination. Ensure your vaccinations are up to date in line with national guidance.

Can molnupiravir cause problems?

Along with their useful effects, most medicines can cause unwanted side-effects although not everyone experiences them. The table below contains some of the most common ones associated with molnupiravir. You will find a full list in the manufacturer's information leaflet supplied with your medicine. The unwanted effects often improve as your body adjusts to the new medicine, but speak with your doctor or pharmacist if any of the following continue or become troublesome.

Common molnupiravir side-effects (affecting fewer than 1 in 10 people)

Vad kan jag göra om jag upplever detta?

Diarré

Drink plenty of water to replace lost fluids

Känner dig illamående (nausea)

Stick to simple foods. Try taking your doses with something to eat if you are not already doing so

Yrsel

Do not drive and do not use tools or machines if affected

Viktigt: In rare cases this medicine may cause a serious allergic reaction. Seek urgent medical attention if you develop a red, itchy skin rash and any difficulties with your breathing, including swelling of the face, lips or tongue. Taking an antihistamine may help slow the reaction whilst you are waiting for treatment.

Om du upplever några andra symtom som du tror kan bero på denna medicin, tala med din läkare eller apotekare.

How to store molnupiravir capsules

  • Förvara alla läkemedel utom räckhåll och synhåll för barn.

  • Förvara på en sval, torr plats, borta från direkt värme och ljus.

Viktig information om alla läkemedel

Viktig information om alla läkemedel

Ta aldrig mer än den föreskrivna dosen. Om du misstänker att du eller någon annan kan ha tagit en överdos av denna medicin, gå till akutmottagningen på ditt lokala sjukhus. Ta med behållaren, även om den är tom.

Denna medicin är för dig. Ge den aldrig till andra människor även om deras tillstånd verkar vara detsamma som ditt.

Behåll inte föråldrade eller oönskade mediciner. Ta dem till ditt lokala apotek som kommer att ta hand om dem åt dig.

Om du har några frågor om denna medicin, fråga din apotekare.

Rapportera biverkningar av ett läkemedel eller vaccin

Om du upplever biverkningar kan du rapportera dem online via Yellow Card webbplats.

symptomkontroll

Osäker på att blanda mediciner?

Kontrollera möjliga interaktioner mellan läkemedel, kosttillskott och livsmedel innan du tar dem tillsammans.

Vanliga frågor

What is the age range for taking molnupiravir?

Molnupiravir is specifically used for adults aged 18 and over who have tested positive for COVID-19.

Why is it important to complete the full five-day course of molnupiravir, even if I feel better?

Completing the full course of treatment helps ensure the medication effectively stops the virus from replicating, which can reduce the severity of the infection and lower your risk of being severely ill or requiring hospitalisation. It's crucial to finish the entire course to give the medicine the best chance to work, even if your symptoms improve.

What should I do if I accidentally take two doses of molnupiravir at once?

You should never take two doses together to make up for a missed dose. If you suspect you or someone else might have taken an overdose of this medicine, you should go to the accident and emergency department of your local hospital immediately. Remember to take the medicine container with you, even if it is empty.

What are the common symptoms of a severe allergic reaction to molnupiravir?

Signs of a serious allergic reaction include a red, itchy skin rash, difficulties with your breathing, and swelling of the face, lips, or tongue. If you experience any of these symptoms, you should seek urgent medical attention.

Does molnupiravir interact with any other medications I might be taking?

Before starting molnupiravir, it's important to inform your doctor about all other medicines you are currently taking. This includes any over-the-counter medicines, as well as herbal and complementary medicines. Your doctor needs this information to ensure molnupiravir is suitable for you and to check for potential interactions.

Dessa frågor och svar har genererats från informationen i denna artikel.

Vidare läsning och referenser

Om författarenVisa fullständig biografi

Författarbild

Michael Stewart, MRPharmS

Ansvarig för granskning av medicinbroschyrer – Konsult, Apotekare

BPharm (Hons), MRPharmS

Michael är en apotekare som arbetar i Midlands och South Yorkshire med mer än 20 års erfarenhet av att ge råd om läkemedel och medicinska tillstånd. Han har en stark bakgrund inom vårdutbildning och har producerat och levererat utbildningskurser för apoteksteam och personal inom vårdboenden, inklusive sjuksköterskor. Han har också bidragit till apoteksrådgivande styrelser för hantering av mindre allvarliga tillstånd i samhället.

Om recensenten

Författarbild

Sid Dajani

Sultan Dajani tog examen vid London School of Pharmacy 1994 och blev den yngsta valda medlemmen i Royal Pharmaceutical Society-rådet sedan dess grundande 1842.

Artikelhistorik

Informationen på denna sida är skriven och granskad av kvalificerade kliniker.

Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.

  • Nästa granskning: 15 dec 2027
  • 15 dec 2024 | Senaste versionen

    Senast uppdaterad av

    Michael Stewart, MRPharmS

    Granskad av

    Sid Dajani
influensaberättigandekontroll

Fråga, dela, anslut.

Bläddra i diskussioner, ställ frågor och dela erfarenheter inom hundratals hälsorelaterade ämnen.

Anmäl dig till Patientens nyhetsbrev

Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.

Vänligen ange en giltig e-postadress

Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

Mer inom infektionsbehandling

Visa mer inom infektionsbehandling medicin